PROTOCOLO DE INVESTIGACION No.
Fecha:_______________________Número de Biopsia:__________________ Nombre:________________________________________________________ Sexo: Masculino Edad:_______años. No. Expediente:___________________ Médico Solicitante: Dr. Hugo A. Manzanilla García.
Pieza Operatoria: Biopsias de próstata.
Operación: Biopsias al azar guiadas por ultrasonido de próstata. Diagnóstico Clínico: Descartar Carcinoma de Próstata.
Biopsias anteriores: No.
Antígeno Prostático Específico:__________ ng/dL. Fracción Libre:_______%.
© HAMG © HAMG
D = Lóbulo derecho I = Lóbulo Izquierdo
3 Apex Lateral Der. Apex Medio Der. Apex Medio Izq. Apex Lateral Izq. 2 Medio Lateral Der.
Medio Medio Der. Medio Parasagital Der. Medio Parasagital Izq. Medio Medio Izq. Medio Lateral Izq.
BIBLIOGRAFIA.
1. Penson FD, Chan MJ. Próstata Cancer. The Journal of Urology. Junio 2007; 177: 2020-2029.
2. Powell JI. Epidemiology and Pathophysiology of Prostate Cancer in African- American Men. The Journal of Urology. Febrero 2007; 177: 444-449.
3. Makridakis MN, Reichardt VK. Molecular epidemiology of Androgen-Metabolic loci in Prostate Cancer: Predisposition and Progresion. The Journal of Urology. Febrero 2004; 171: S25-S29.
4. Platz AE, De Marzo MA. Epidemiology of Inflmation and Prostate Cancer. The Journal of Urology. Febrero 2004; 171: S36-S40.
5. Epstein IJ, Potter RS. The Pathological Interpretacion and Significance of Prostate Needle Biopsy Findings: Implications and Current Controversies. The Journal of Urology. Agosto 2001; 166: 402-410.
6. Balk PS, Ko Yoo-Joung, Bubley JG. Biology of Prostate-Specific Antigen. Journal of Clinical Oncology. Enero 2003; 21(2): 383-391.
7. Lam SJ, Leppert TJ, Vemulapalli NS, et.al. Secondary Hormonal Theray for Advanced Prostate Cancer. The Journal of Urology. Enero 2006; 175: 27-34.
8. Parsons KJ, Partin WA. Clinical Interpretacion of Prostate Biopsy Reports. Urology. 2005; 67: 452-457.
9. Tanagho AE, McAninch WJ, et al. Urologia General de Smith. 13a Edición. México. Manual Moderno.2005: 357-375.
10. Aus G, Abbou C, Bolla M, et al. Guidelines on Prostate Cancer. Pocket Guidelines. European Association of Urology. Marzo 2005: 21-35.
1 Base Lateral Der. Base Medio der. Base Parasagital Der. Base Parasagital Izq. Base Medio Izq. Base Lateral lzq.
11. Kawachi HM, Bahnson RR, Barry M, et al. Prostate Cancer Early Detection. NCCN Clinical Practice Guidelines in Oncology. 2007.
12. Adams CM, Alfert JH, Appell AR, et al. Campell Urología. 8a Edición. Tomo 4. Editorial Médica Panamericana. 2005: 3285-3374.
13. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies for the prostate. J Urol 1989; 142:71-5. 1. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution for prostatic
adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12:897-906.
2. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995; 45:2-12.
3. Uzzo RG, Wei JT, Waldbaum RS, et al. The influence of prostate size on cancer detection. Urology 1995; 46: 831-6.
4. Karakiewicz PI, Bazinate M, Aprikian AG, et al. Outcome of sextant biopsy according to gland volume. Urology 1997; 49: 55-9.
5. Daneshgari F, Taylor GD, Miller GJ, Crawford D. Computer Simulation of the probability of detecting low volume carcinoma of the prostate with six random systematic core biopsies. Urology 1995; 45: 604-9.
6. Bauer JJ, Zeng J, Weir J, et al. Three-dimensional computersimulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology 1999; 53: 961-7.
7. Chen ME, Troncoso P, Tang K, et al. Comparison of prostate biopsy schemes by computer simulation. Urology 1999; 53: 951-60.
8. Karakiewicz PI, Aprikian AG, Meshref AW, Bazinet M. Computer-assisted comparative analysis of four-sector and six-sector biopsies of the prostate. Urology 1996;48 : 747-50.
9. Eskew LA, Bare Rl, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157:199-203.
10. Norberg M, Egevad L, Holmberg L, et al. The sextant protocol for ultrasound- guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50: 562-6.
11. Chang JJ, Shinohara K, Bhargava V, Presti JC Jr. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998; 160:2111-4.
12. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include eight rather than six biopsies-results of a prospective clinical trial. J Urol 2000; 163:163-6.
13. Vashi AR, Wojno KJ, Gillespie B, Oesterling JE. A number for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol 1998; 159:920-4.
14. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998; 159:471-6.
15. McNeal JE, Villers AA, Redwine EA, et al. Capsular penetration in prostate cancer: significance for natural history and treatment. . Am J Surg Pathol 1990; 14:240-7. 16. Terris MK, Pham TQ, Issa MM, Kabalin JN. Routine transition zone and seminal
vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J Urol 1997; 157:204-6.
17. Bazinet M, Karakiewicz PI, Aprikian AG, et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol 1996; 155:605-6.
18. Chang JJ, Shinohara K, Hovey RM, et al. Prospective evaluation of systematic sextant transition zone biopsies in large prostates for cancer detection Urology 1998;52 : 89-93.
19. Fowler JE Jr, Bigler SA, Kilambi NK, Land SA. Results of transition zone biopsy in Black and White men with suspected prostate cancer. Urology 1999;53 : 346-50. 20. Lui PD, Terris MK, McNeal JE, Stamey TA. Indications for ultrasound guided
transition zones biopsies in the detection of prostate cancer. J Urol 1995; 153:1000-3.
21. Keetch DW, Catalona WJ. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. J Urol 1995; 154:1795-7.
22. Fleshner NE, Fair WR. Indications for transition zone biopsy in the detection of prostatic carcinoma. J Urol 1997; 157:556-8.
23. Chang JJ, Alberts G, Wells N, et al. Intrarectal lidocaine during transrectal prostate biopsy: results of a prospective double blind randomized trial. J Urol 2001; 166:2178-80.
24. Desgrandchamps F, Meria P, Irani J, et al. The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography-guided biopsy of the prostate: a prospective randomized placebo-controlled study. BJU Int 1999; 83:1007-9.
25. Leibovici D, Zisman A, Siegel YI, et al. Local anesthesia for prostate biopsy by periprostatic lidocaine injection: a double-blind placebo controlled study. J Urol 2002; 167:563-5.
26. Alavi AS, Soloway MS, Vaidya A, et al. Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods. J Urol 2001; 166:1343-5.